EA at ST36 and ST37 improved visceral hyperalgesia, decreased c-Fos, and NMDAR expression in the RVM in IBS model rats (Qi and Li 2012), suggesting an analgesic effect of EA, which may mediated by inhibiting NMDAR activation in the RVM. The gene discussed is FOS; the disease is irritable bowel syndrome.